Scholar Rock Holding (SRRK) Receivables (2019)

Scholar Rock Holding (SRRK) posted quarterly Receivables of $25.0 million for Q4 2019.

Scholar Rock Holding (SRRK) Receivables (2019) Analysis & Trends

Scholar Rock Holding's Receivables history runs 1 years deep, the most recent figure standing at $25.0 million for Q4 2019.

In Q4 2019, Receivables changed N/A year-over-year to $25.0 million; the TTM figure through Dec 2019 stood at $25.0 million (changed N/A YoY), while the FY2019 annual figure was $25.0 million, changed N/A from the prior year.
Receivables for Q4 2019 stood at $25.0 million.
The five-year high for Receivables was $25.0 million in Q4 2019, with the low at $25.0 million in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.13 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	6.57 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.93 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.06 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	1.84 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	912.74 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	215.33 Mn
10	Scholar Rock Holding	6.39 Bn	6.39 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	25.00 Mn